RecruitingNCT04117321

Mother-infant Microbiota Transmission and Its Link to the Health of the Baby


Sponsor

Chinese University of Hong Kong

Enrollment

20,000 participants

Start Date

Sep 23, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

The human intestinal tract harbors a diverse and complex microbial community, known as gut microbiota, which is critical in sustaining physiology, metabolism, nutrition and immune function. Dysbiosis of gut microbiota has been linked with obesity, hyperglycemia, hyperlipidemia, inflammatory bowel disease and other chronic inflammatory diseases. Gut microbiota is affected by host genetic markup, diet and life style; and therefore varied by human races and geographical locations. The development of gut microbiota starts before birth. The infant's microbiome can impact on human health in later life. The microbiome of pregnant women are associated with early-life microbiota of their offspring as well as growth, neurodevelopment and the development of allergic and neurocognitive disorders. Early childhood, when the microbiota is less mature and more malleable, is a golden age for microbiota manipulation to prevent disease. Studying microbiota at this golden age also allow us to dissect the development of a faulty microbiota and identify therapeutic targets to reverse it and cure diseases that are already developed.


Eligibility

Inclusion Criteria6

  • Pregnant women
  • Being pregnant
  • Plan to give birth in local hospital
  • Competent to provide informed consent (no mental illness or dementia, etc. that will hinder their ability to undertake informed consent)
  • Be a new born baby of an enrolled pregnant woman
  • Biological father of an enrolled new born baby

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Prince of Wales Hospital

Hong Kong, Hong Kong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04117321


Related Trials